Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (387)
- Scheduling (national classification system) (168)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
768 result(s) found, displaying 551 to 575
-
Corporate reportsInternational engagement: how TGA collaborates to share learnings, align policies, standards and regulatory processes
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 October 2018
-
Meeting statementsThe Advisory Committee on Medicines meeting statement is now available
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 18 meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 19 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in March 2018
-
Corporate reportsPost-market vigilance statistics for 2017
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Corporate reportsDescribes the interaction, role and responsibilities of the TGA and NATA in relation to the regulation of in-house IVDs.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsNew chemical entities registered in 2017 in Australia.
-
Meeting statementsAdvisory Committee on Medicines
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsAbout compositional guidelines for ingredients permitted for use in listed medicines.
-
Corporate reportsThis guideline is an internationally accepted standard for the designing, conducting, recording and reporting of clinical trials.
-
Scheduling decisions (final)Delegate only final scheduling decisions on NCEs now available
-
Scheduling decisions (interim)Interim decisions to amend, or not amend, the Poisons Standard with respect to substances referred to the March 2018 ACMS/ACCS now available
-
Meeting statementsACM meeting statement, meeting 8, April 2018
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsSubmissions received on the proposed regulatory changes related to personalised and 3D printed medical devices have been published.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement